These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17314219)

  • 1. Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland.
    Pituch H; van Leeuwen W; Maquelin K; Wultańska D; Obuch-Woszczatyński P; Nurzyńska G; Kato H; Reijans M; Meisel-Mikołajczyk F; Łuczak M; van Belkum A
    J Clin Microbiol; 2007 May; 45(5):1607-10. PubMed ID: 17314219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006.
    Pituch H; Obuch-Woszczatyński P; Wultańska D; Nurzyńska G; Harmanus C; Banaszkiewicz A; Radzikowski A; Łuczak M; van Belkum A; Kuijper E
    J Med Microbiol; 2011 Aug; 60(Pt 8):1200-1205. PubMed ID: 21415206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B; Wojno J; Abratt V; Reid SJ
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing.
    Joost I; Speck K; Herrmann M; von Müller L
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S13-8. PubMed ID: 19303562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017.
    Wang B; Peng W; Zhang P; Su J
    FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30085003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.
    Yang J; Zhang X; Liu X; Cai L; Feng P; Wang X; Zong Z
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):161-163. PubMed ID: 28800896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
    Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
    Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
    Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile causing pediatric infections: New findings from a hospital-based study in Italy.
    Spigaglia P; Barbanti F; Castagnola E; Diana MC; Pescetto L; Bandettini R
    Anaerobe; 2017 Dec; 48():262-268. PubMed ID: 29066337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
    Adams DA; Riggs MM; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2674-8. PubMed ID: 17562807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of susceptibility of strictly anaerobic bacteria originated from different sources to fluoroquinolones and other antimicrobial drugs].
    Lachowicz D; Skopińska E; Pawłowska J; Kostkiewicz M; Obuch-Woszczatyński P; Wultańska D; Pituch H
    Med Dosw Mikrobiol; 2012; 64(2):115-22. PubMed ID: 23072056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998.
    Tang-Feldman YJ; Henderson JP; Ackermann G; Feldman SS; Bedley M; Silva J; Cohen SH
    Clin Infect Dis; 2005 May; 40(10):1537-40. PubMed ID: 15844079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
    Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
    Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
    Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profile of toxigenicity of Clostridium difficile strains isolated from paediatric patients with clinical diagnosis of antibiotic associated diarrhea (AAD)].
    Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2005; 57(4):377-82. PubMed ID: 16773831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
    Akerlund T; Svenungsson B; Lagergren A; Burman LG
    J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
    Huang H; Fang H; Weintraub A; Nord CE
    Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.